Introducing Our New Residents

March 20, 2015

The Pathology Residency Program matched eight medical students (five MDs and three MD/PhDs) with a variety of academic career goals for training in AP/CP, AP only and CP only.

Read more

NIH Award to Develop Synthetic DNA Vaccines to Fight HIV

March 12, 2015

The NIAID has awarded $16 million to a collaborative group led by Dr. David Weiner to develop the next generation of HIV vaccines.

Read more

Dr. Carl June is Co-Recipient of the 2015 Paul Ehrlich Prize

March 07, 2015

Awarded for his groundbreaking contributions to the field of immunotherapy against cancer.

Read more

Making Gene Therapy a Reality

March 05, 2015

A recent WHYY Newsworks radio report highlights the promise of gene therapy after "more than three decades of trial and error."

Read more

Genes and Development Study Describes Function of an Enzyme Critical to Male Fertility

March 04, 2015

Dr. Zissimos Mourelatos is senior co-author of a study that describes how RNA helicase MOV10L1 protects the integrity of the germ line by giving rise to a class of RNA molecules that are essential to sperm development.

Read more

The T-Cell Warriors

March 03, 2015

Portrait of a revolutionary approach to cancer treatment in the Pennsylvania Gazette.

Read more

I’d Rather Be in Philadelphia

Published by Elizabeth Azzato, MD, PhD, and other Pathology Residents, on January 30, 2015

A persistent legend has it that the epitaph on the tombstone of W.C. Fields reads “I’d rather be in Philadelphia.” Here are some questions that many of us had when we first considered enrolling in the Pathology Residency Program at Penn and that you might have as well if you don’t know Philly yet.

Read more

Precision Medicine Initiative

January 23, 2015

Dr. David Roth, Director of the Penn Medicine Precision Medicine Program, explains the complexities and the challenges of precision medicine in an interview with WHYY's The Pulse.

Read more

Nature Communications Study Finds New Biomarker Possibilities for Rare Neuroendocrine Tumors

January 21, 2015

A new study published in Nature Communications finds that a mutation in the ATRX gene, a potential molecular marker for aggressive brain tumors, can also serve as a much-needed biomarker for rare neuroendocrine tumors.

Read more